BioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™

BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces FDA clearance of the rechargeable BioButton® Multi-Patient wearable and BioDashboard™ system to cost-effectively grow and scale hospital virtual care programs…. The post BioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™ appeared first on BioIntelliSense .